Navigation Links
Bayer HealthCare Provides Nearly $2.5 Million to Advance Hemophilia Research and Patient Care
Date:7/28/2011

WAYNE, N.J., July 28, 2011 /PRNewswire/ -- Bayer HealthCare today announced the 2011 recipients of the Bayer Hemophilia Awards Program (BHAP).  This year, the company has awarded nearly $2.5 million in funding to 18 recipients from 12 countries, including the U.S.  BHAP, the largest program of its kind for the hemophilia community, was created to help improve the understanding and treatment of hemophilia and related bleeding disorders.  The program also seeks to reduce the disease's impact on individuals and their communities, and support the next generation of care and treatment options worldwide for people with hemophilia.

BHAP supports research in bleeding disorders, ranging from studies to better understand inhibitor development and methods for treatment, gene therapy and joint care to the development of pediatric care models in underserved markets and hemophilia counseling.

"We're very pleased to award and congratulate these future hemophilia thought leaders for their exemplary passion, talent and expertise," said John E. Murphy, Ph.D., Director, Molecular Biology, Biologics Research, Bayer HealthCare. "BHAP is a reflection of Bayer's commitment to expanding the scientific and clinical knowledge that improves patient care."

The 2011 BHAP recipients were selected by a global committee of distinguished hemophilia clinicians, researchers and caregivers, and were honored at the BHAP award ceremony held in conjunction with the International Society of Thrombosis and Haemostasis (ISTH) Annual Meeting in Kyoto, Japan.  Among this year's winners are:

  • Dr. John Sheehan of the University of Wisconsin, for "Contribution of the heparin binding exosite to factor IX clearance and in vivo activity"
  • Dr. Carol Miao, Seattle Children's Research Institute, for "Immunimodulation to eradicate anti-factor VIII inhibitory antibodies"
  • Dr. Paris Margaritis, The Children's Hospital of
    '/>"/>

SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  A Boston Scientific ... study on stent removability and preliminary long term ... published in the August issue of the peer-reviewed ... 1 is being conducted in 11 countries ... covered self-expanding metal stents (FCSEMS) after extended indwell ...
(Date:8/29/2014)...  BC Technical, the nation,s leading non-OEM provider of ... leader in sales, service and installation of GE MRI ... to continue to expand their resources and inventory while ... "We are committed to driving higher ... president and CEO of BC Technical. "We set out ...
(Date:8/29/2014)... , August 29, 2014 ... Seed Oil Market by Extraction type (SFE, Cold ... & Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) ... by MarketsandMarkets, defines and segments the Amaranth Seed ... the market size in terms of value. The ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4BC Technical Acquires Polaris Medical Imaging 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... Dec. 7 In addition to data released in ... the Company,s PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation ... with moderate-to-severe Crohn,s disease. While the earlier announcement ... from the Maintenance period of the study showed that ...
... , WESTWOOD, Mass., Dec. 7 CompuCyte Corporation, ... and the leading supplier of laser scanning cytometers, announced ... of imaging cytometers to include four-laser versions of the ... four excitation lasers chosen from a palette of 405, ...
Cached Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2
(Date:8/29/2014)... 30, 2014 UWDress.com, one of the ... its latest collection of 2014 floor length bridesmaid ... for these wonderful items. According to the company’s marketing ... a greatly discounted rate (up to 60 percent off) ... products has a special neckline: strapless, one-shoulder, bateau and ...
(Date:8/29/2014)... August 29, 2014 As reported by WKMS.com ... Recovery , an Ohio municipal court drug has come up ... Fred Moses, who serves as the presiding judge in a ... makers to offer addicts a medicated treatment option that can ... the drug known as Vivitrol, which blocks receptors in the ...
(Date:8/29/2014)... 29, 2014 As reported by GantDaily.com in ... Drug Abuse Trends , Outbreaks (8/20), the National Institute on ... monitor drug abuse trends by turning to social media. As ... trends, it is also working with the University of Maryland ... Early Warning System, which will be funded by the National ...
(Date:8/29/2014)... 29, 2014 As reported by the Frederick News ... Court Grad (8/17), a graduate of the Frederick County Drug ... his own experience with the program. The graduate, Korey Shorb, put ... a 1 mile walk. He plans to donate the proceeds of ... to those who helped him. Shorb, who graduated in 2008, admitted ...
(Date:8/29/2014)... Dallas, Texas (PRWEB) August 30, 2014 ... Glass microfiber Industry, 2009-2019 is a professional and ... microfiber industry. The report firstly reviews the basic ... and manufacturing technology. The report then explores global ... their product specification, capacity, Production value, and market ...
Breaking Medicine News(10 mins):Health News:2014 Floor Length Bridesmaid Dresses for Sale at UWDress.com 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:Drug Court Grad Brings More Life to Drug Court Program 2Health News:Drug Court Grad Brings More Life to Drug Court Program 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4
... 24 TrinityCare Senior Living, Inc. (formerly OTCBB: JKAN) ... living facilities, today announced that its Board of Directors ... of the public entity from July 31st to December ... re-domicile and re-incorporation was completed and approved on February ...
... Though the American Medical Association and others have called ... and though some big pharma companies have recently moved ... for CME by third-party vendors), 75 - 100 percent ... hospitals is funded by the bio-pharma industry. As one ...
... up for spring, the winter storms that left many ... situations can occur without warning. To ensure that we ... Health Association,s (APHA) "Get Ready: Set Your Clocks, Check ... preparedness kits when they change their clocks on March ...
... Show Evidence of Differential Gene Expression in Patients ... shown that prostate biopsy samples taken from surgically ... vitamin supplements can be used to investigate their ... between tumor samples from patients who had taken ...
... N.C. -- Ancient groundwater being tapped by Jordan, one of ... found to contain twenty times the radiation considered safe for ... of researchers. , "The combined activities of 228 radium ... in the groundwater we tested are up to 2000 ...
... Inc., a,manufacturer of point-of-care robotic systems for the ... hired Jeffrey S.,Jones to serve as the Company,s ... executive, joined the PolyRemedy management team in,January 2009. ... in growing innovative medical device companies, Jeff,brings a ...
Cached Medicine News:Health News:TrinityCare Senior Living, Inc. Changes Fiscal Year End to December 31st 2Health News:Educating the Market: Creating Value Through Support of Continuing Medical Education 2Health News:Check Your Emergency Stocks When You Change Your Clocks, Says APHA 2Health News:Also in the Feb. 24 JNCI 2Health News:Also in the Feb. 24 JNCI 3Health News:Also in the Feb. 24 JNCI 4Health News:Jordan's fossil water source has high radiation levels 2Health News:Jordan's fossil water source has high radiation levels 3Health News:PolyRemedy Names Jeffrey Jones as Its Chief Operating Officer 2
Aaron burr 4 handle for corneal rust ring removal...
Aaron Burr II with disposable 1mm burr for corneal rust ring removal and a diamond burr tip for polishing the pterygium bed after surgical removal and for lid margin lesions....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Medicine Products: